These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5535614)

  • 1. Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis.
    Urbancik B
    Antibiot Chemother; 1970; 16():281-6. PubMed ID: 5535614
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and bacteriological results with Myambutol.
    Goldman S; Brzaković N; Muzikravić T
    Antibiot Chemother; 1970; 16():239-56. PubMed ID: 4332036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 6. Report on experiences with ethambutol.
    Böszörményi M
    Antibiot Chemother; 1970; 16():292-3. PubMed ID: 5535615
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of urogenital tuberculosis].
    König K
    Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with ethambutol.
    Wilson TM
    Antibiot Chemother; 1970; 16():222-9. PubMed ID: 4108890
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
    Dickinson JM
    Bull Int Union Tuberc; 1968 Dec; 41():309-15. PubMed ID: 4179554
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ
    Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
    Virchow C
    Munch Med Wochenschr; 1969 Aug; 111(35):1717-22. PubMed ID: 4309162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
    Jesiotr M
    Tubercle; 1969 Mar; 50():Suppl:54-5. PubMed ID: 4319133
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental therapy with rifampicin.
    Yoshida F
    Antibiot Chemother; 1970; 16():416-23. PubMed ID: 5535616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.